Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide versus mycophenolate mofetil in children with steroid-dependent nephrotic syndrome
2009-011406-42Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in nephrosis comparing Cyclophosphamide arm with Mycophenolate mofetil arm (2 arms). Primary endpoint: Occurrence of first nephrotic relapse within 24 months. Started Jul 2009; status: active.
02
Drugs
cyclophosphamidemycophenolate mofetil
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2009-011406-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011406-42.